Add like
Add dislike
Add to saved papers

The prevalence and associated factors of new psychoactive substance use: A 2016 Thailand national household survey.

Introduction: Analyzing the situation and risk factors associated with using new psychoactive substances (NPS) is essential for preventing and controlling health consequences. This study explored the prevalence and associated factors of NPS use in the Thai population.

Methods: This descriptive study was conducted in participants (N = 30,411, mean age = 42.4 ± 13.4 years, range = 15-64 years, 50.3% women) from urban and rural areas of Thailand. The participants were chosen using multistage sampling for large populations. The data were collected in July-December 2016 and analyzed using frequency, percentage, mean, standard deviation, chi-square, multiple logistic regression, and odds ratio with 95% confidence intervals (CI).

Results: The prevalence of lifetime NPS use was 49.7% (95% CI, 49.1-51.3), past-year use was 31.3% (95% CI, 30.8-31.8), and current (past-month) use was 14.9% (95% CI, 14.5-15.3). Among current users, 29.5% were habitual users (over 20 days). The factors associated with current NPS use were sex (male/female) (adjusted odds ratio [AOR] = 1.145; 95% CI, 1.075-1.221; p < 0.001), age group (25-64/15-24 years) (AOR = 1.126; 95% CI, 1.090-1.358; p < 0.001), educational attainment (elementary or secondary education and higher) (AOR = 1.634; 95% CI, 1.529-1.747; p < 0.001), and employment status (AOR = 1.842; 95% CI, 1.683-2.016; p < 0.001).

Conclusions: The prevalence of NPS use in Thailand is high, which reflects abuse behavior that could potentially harm users. Understanding the prevalence and risk factors of NPS use could benefit policymakers.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app